Search clinical trials for: Genentech BRAF inhibitor
Total 68402 results
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Metastatic Malignant Solid Neoplasm | Unresectable Solid Neoplasm | BRAF NP_004324.2:p.V600X | KRAS wt AlleleUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteGenentech, Inc.; ExelixisActive, not recruitingMelanoma | Skin CancerUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityWithdrawnAnatomic Stage III Breast Cancer AJCC v8 | Recurrent Ovarian Carcinoma | Anatomic Stage IV Breast Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Advanced Pancreatic Carcinoma | Stage II Pancreatic Cancer AJCC v8 | Stage III Pancreatic Cancer AJCC v8 | Stage IV Pancreatic Cancer AJCC v8 | Recurrent... and other conditionsUnited States
-
University of California, San FranciscoGenentech, Inc.Active, not recruitingPediatric Recurrent/Refractory BRAFV600E-mutant GliomasUnited States, Canada
-
M.D. Anderson Cancer CenterGenentech, Inc.Active, not recruiting
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.Active, not recruiting
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
Southwest Oncology GroupNational Cancer Institute (NCI); Roche-GenentechCompletedColorectal CancerUnited States
-
Philip FriedlanderGenentech, Inc.TerminatedMelanomaUnited States
-
Genentech, Inc.Completed
-
Genentech, Inc.CompletedMetastatic Melanoma, BRAF V600 Mutation PositiveKorea, Republic of, Russian Federation, Israel, United States
-
Mohammed M MilhemGenentech, Inc.TerminatedMelanoma | Metastatic Melanoma | BRAF-mutated Metastatic Melanoma | V600EBRAF-mutated Metastatic MelanomaUnited States
-
Melanoma Research Foundation Breakthrough ConsortiumGenentech, Inc.TerminatedMelanoma | Metastatic MelanomaUnited States
-
Genentech, Inc.Terminated
-
Yale UniversityGenentech, Inc.Completed
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Genentech, Inc.WithdrawnMelanomaUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Genentech, Inc.WithdrawnRecurrent Melanoma | Stage IV Melanoma | Tumors Metastatic to Brain
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.CompletedMetastatic Colorectal CancerUnited States
-
Bristol-Myers SquibbRoche-GenentechTerminated
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingMantle Cell LymphomaUnited States
-
Sun Yat-sen UniversityRecruitingColorectal Cancer | Liver MetastasesChina
-
Ikena OncologyRecruitingColorectal Cancer | Pancreatic Cancer | Thyroid Carcinoma | Solid Tumor, Adult | Malignant Melanoma | Non-Small Cell Lung Carcinoma | BRAF Gene Mutation | Gliomas, Malignant | Ras (Kras or Nras) Gene Mutation | CRAF Gene MutationUnited States
-
Shandong UniversityNot yet recruiting
-
Novartis PharmaceuticalsRecruitingBRAF V600E Mutation-positive Unresectable Advanced or Recurrent Solid TumorJapan
-
C. Babis AndreadisEli Lilly and Company; Genentech, Inc.; Adaptive BiotechnologiesNot yet recruitingMantle Cell LymphomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Genentech, Inc.RecruitingOropharynx Cancer, Stage IUnited States
-
OHSU Knight Cancer InstituteGenentech, Inc.; Oregon Health and Science UniversityNot yet recruitingDiffuse Large B-Cell Lymphoma | High Grade B-Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterGenentech, Inc.RecruitingMantle Cell Lymphoma | MCLUnited States
-
Children's Hospital of PhiladelphiaGenentech, Inc.RecruitingInfections | Influenza | Transplant | Infection Viral | Infection, CoronavirusUnited States
-
Memorial Sloan Kettering Cancer CenterMerck Sharp & Dohme LLC; Genentech, Inc.RecruitingEsophageal Cancer | Gastric Adenocarcinoma | HER2 Gene MutationUnited States
-
Vanderbilt-Ingram Cancer CenterGenentech, Inc.RecruitingStage IV Lung Cancer | Extensive Stage Lung Small Cell CarcinomaUnited States
-
National Cancer Institute (NCI)RecruitingMetastatic Colorectal Adenocarcinoma | Refractory Colorectal Adenocarcinoma | Stage IV Colorectal Cancer AJCC v8United States
-
Genentech, Inc.Recruiting
-
Leiden University Medical CenterNovartisRecruitingAnaplastic Thyroid CancerNetherlands
-
Sun Yat-sen UniversityNot yet recruitingNSCLC | BRAF V600 Mutation | MET Exon 14 MutationChina
-
Christine RyanGenentech, Inc.RecruitingChronic Lymphocytic Leukemia | Richter's TransformationUnited States
-
Genentech, Inc.RecruitingLocally Advanced Solid Tumors | Metastatic Solid Tumors | Recurrent Solid TumorsAustralia, United States
-
PfizerRecruiting
-
Roswell Park Cancer InstituteRecruitingColo-rectal CancerUnited States
-
Shanghai Kechow Pharma, Inc.Not yet recruitingColorectal Cancer Metastatic
-
University of Texas Southwestern Medical CenterGenentech, Inc.RecruitingColorectal CancerUnited States
-
Daping Hospital and the Research Institute of Surgery...Not yet recruitingNSCLC | Advanced Cancer | Stage IV NSCLC | BRAF V600E Mutation | Stage IIIB NSCLC
-
Joshua PalmerGenentech, Inc.RecruitingNSCLC | Lung Cancer | Brain MetastasesUnited States
-
Genentech, Inc.BioNTech SERecruiting
-
Zhejiang Cancer HospitalNot yet recruitingAdvanced Colorectal CancerChina
-
Sun Yat-sen UniversityRecruiting
-
Genentech, Inc.RecruitingColorectal Cancer | Non-Small Cell Lung CancerKorea, Republic of, Australia, United States
-
PfizerMerck Sharpe & Dohme LLCRecruitingMelanomaItaly, Spain, Czechia, Germany, Slovakia, Poland, United Kingdom
-
Shanghai Kechow Pharma, Inc.Not yet recruiting